Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2010 | 05-2009 | 05-2008 | 05-2007 | 05-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -332 | 354 | 1,710 | 509 | 154 |
| Depreciation Amortization | 114 | 89 | 66 | 57 | 122 |
| Income taxes - deferred | N/A | -68 | -170 | N/A | N/A |
| Accounts receivable | -314 | -29 | -135 | 4 | -441 |
| Other Working Capital | 83 | -693 | -745 | -248 | -431 |
| Other Operating Activity | 211 | 244 | -921 | 142 | 212 |
| Operating Cash Flow | $-237 | $-102 | $-195 | $464 | $-384 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 100 | -100 | 1,781 | N/A | 1 |
| PPE Investments | -316 | -86 | -265 | -63 | -252 |
| Purchase Sale Intangibles | -54 | -30 | N/A | N/A | N/A |
| Other Investing Activity | -54 | -30 | 0 | 0 | 0 |
| Investing Cash Flow | $-269 | $-216 | $1,516 | $-63 | $-252 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 65 |
| Debt Issued | N/A | 133 | 120 | 62 | N/A |
| Debt Repayment | -42 | -273 | -84 | -97 | -67 |
| Common Stock Issued | 10 | 36 | 149 | 31 | 503 |
| Common Stock Repurchased | N/A | -3 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 37 |
| Financing Cash Flow | $-32 | $-107 | $184 | $-4 | $539 |
| Exchange Rate Effect | -2 | -2 | N/A | N/A | N/A |
| Beginning Cash Position | 1,596 | 2,022 | 517 | 120 | 352 |
| End Cash Position | 1,055 | 1,596 | 2,022 | 517 | 120 |
| Net Cash Flow | $-541 | $-427 | $1,506 | $397 | $-232 |
| Free Cash Flow | |||||
| Operating Cash Flow | -237 | -102 | -195 | 464 | -384 |
| Capital Expenditure | -316 | -86 | -265 | -113 | -252 |
| Free Cash Flow | -553 | -188 | -459 | 351 | -637 |